It began last Monday in Washington, D.C., with the U.S. Food and Drug Administration's (FDA) advisory panel convening for 12 hours to make recommendations on Sarepta Therapeutic, Inc.'s controversial drug for a rare form of muscular dystrophy that ... BioSpace, 11 hours ago
Why Sarepta Didn't Start a Big DMD Trial Quicker - BioSpace, 8 hours ago
Another Fatal-Disease Drug in Limbo - The Scientist, 6 days ago
The US Food and Drug Administration has approved biotech firm Acadia PharmaceuticalsPharma Letter, 1 day ago Acadia Gets FDA Clearance on Drug for Parkinson's-Related Psychosis -- TD Ameritrade, 2 days ago U.S. FDA approves Teva's biotech drug for severe asthma Reuters, 1 month ago
Report Summarizes Biotechnology Study Findings from New Zealand Institute for Plant and Food Research Ltd [Comparison of quantitative real-time...
Report Summarizes Biotechnology Study Findings from New Zealand Institute for Plant and Food Research Ltd [Comparison of quantitative real-time polymerase chain reaction with NanoString ® methodology using adipose and liver tissues from rats ...] ...Equities.com, 4 days ago Allergy Diagnostics And Therapeutics Market Is Anticipated Growth CAGR of 12.0% From 2016 to 2022 Research Report by Hexa Reports TradingCharts.com, 4 days ago
We've been hearing rumours about possible mergers between pesticide/biotech corporations for a while now. Will Monsanto buy Syngenta? Or Bayer? Will the "Big 6" become the "Big 4" or "Big 3" — or perhaps one corporation to rule us all? As the ...Pesticide Action Network, 1 week ago
Rice Consultants LLC - Dallas, TX - . Experience as either a Project Architect or Project Manager is desired. Architect should be proficient on AutoCAD, Architectural Desktop and Revit. Registered Architect should be knowledgeable of construction ...EnvironmentGuru.com, 2 weeks ago
Scientists seeking to bring the brains of dead people back to life have won approval for a groundbreaking trial. A biotech company has been granted ethical permission to find 20 patients who have been declared clinically dead from a traumatic brain ...Melbourne Age, 2 hours ago Biotech firm to start trying to bring dead people back to life MSN UK, 11 hours ago First step in bringing humans 'back from the dead' wins approval WA Today, 11 minutes ago 'Lazarus science' to bring the dead back to life Irish Independent, 1 hour ago
More from: , Sott.net...and 2 other sources
Six months after announcing its first major funding round,Irish biotech company Nuritas has secured fresh investment to bring its total backing up to nearly €5 million. Among the new investors is US billionaire Marc Benioff, the founder and ...Yahoo! Finance UK and Ireland, 10 hours ago Tech billionaire Benioff backs Irish firm Nuritas Irish Independent, 1 day ago
Losses come as Dublin-based company reportedly raises a further €2m in funding Nuritas, the Irish biotechnology start-up that raised $3.2 million in funding late last year, saw accumulated losses rise sharply last year on the back of increased ...Irish Times, 11 hours ago Irish biotech firm Nuritas reports loss after costs rise in first full year of operation Irish Times, 7 hours ago
A biotech firm in the US aiming to research the possibility of regenerating the brains of dead people has been given the go-ahead by a health watchdog. Bioquark has been granted permission by the Institutional Review Board at the National ...Yahoo! UK and Ireland, 9 hours ago
The iShares Nasdaq Biotechnology ETF (NASDAQ: IBB ), which tracks the Nasdaq Biotechnology Index (NASDAQ: NBI ), was under selling pressure last week, down 7.07%, after the Senate Special Committee on Aging conducted its third hearing on Wednesday, ...Seeking Alpha, 1 day ago Cerebrain Biotech to Seek FDA Approval, Shares Move Higher On News BayStreet.ca, 6 days ago
on your WebpageAdd Widget >Get your members hooked!